Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19
Release Date:
This is an all-COVID-19 week. We discuss the WHO Solidarity trial of remdesivir and other antivirals, banlamivimab for outpatients, and an RCT of convalescent serum.
Episode 66: repurposed antivirals, banlamivimab for outpatients, and convalescent serum, all for COVID-19